Bibliotecas PUC-SP - Busca Integrada

Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic

Por Philippe Devillier, MD, PhD, Sarah Saf, MD, Christine Rolland, BA, Giorgio Walter Canonica, MD, Pascal Demoly, MD, PhD
Publicado no World Allergy Organization Journal (2024-04-01)

Hypersensitivity reactions to iodinated radiocontrast media: Cluster analysis reveals distinct clinical phenotypes

Por Witchaya Srisuwatchari, MD, Tram Vo, MD, Amélie Gauthier, MD, Nicolas Molinari, PhD, Rik Schrijvers, MD, PhD, Pascal Demoly, MD, PhD, Anca Mirela Chiriac, MD, PhD
Publicado no World Allergy Organization Journal (2022-09-01)

Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data

Por Margitta Worm, MD, Pascal Demoly, MD, PhD, Yoshitaka Okamoto, MD, PhD, Carmen Vidal, MD, PhD, Katia Daghildjian, PharmD, PhD, Kwok Yan, MD, Thomas B. Casale, MD, Karl-Christian Bergmann, MD, PhD
Publicado no World Allergy Organization Journal (2024-07-01)

Who is at-risk for severe anaphylaxis in France?

Por Luciana Kase Tanno, MD, PhD, Pham Thao Van Luong, MD, MSc, Megane Dieval, MSc, Caroline Dunoyer, PhD, Djito Tevi Lawson, MSc, Nicolas Molinari, PhD, Isabella Annesi-Maesano, MD, PhD, Pascal Demoly, MD, PhD
Publicado no World Allergy Organization Journal (2024-09-01)

Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice: Methodology

Por Davide Caimmi, MD, PhD, Pablo Rodríguez del Río, MD, PhD, Pilar Rico, MD, PhD, Carmen Vidal, MD, Carmen Moreno, MD, Thomas B. Casale, MD, PhD, Pascal Demoly, MD, PhD, Moises A. Calderón, MD, PhD
Publicado no World Allergy Organization Journal (2023-02-01)

Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial

Por Oliver Pfaar, MD, PhD, Frédéric De BLAY, MD, Giorgio Walter Canonica, MD, Thomas B. Casale, MD, PhD, Philippe Gevaert, MD, PhD, Peter W. Hellings, MD, PhD, Krzysztof Kowal, MD, PhD, Giovanni Passalacqua, MD, Miguel Tortajada-Girbés, MD, PhD, Carmen Vidal, MD, PhD, Margitta Worm, MD, PhD, Farah Bahbah, MD, Pascal Demoly, MD, PhD
Publicado no World Allergy Organization Journal (2024-01-01)

CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts

Por Pablo Rodriguez del Rio, MD, PhD, Davide Caimmi, MD, PhD, Pilar Rico Nieto, MD, PhD, Carmen Vidal, MD, PhD, Carmen Moreno, MD, PhD, Maria Teresa González-Fernández, MD, Margarita Tomás-Pérez, MD, Ana Beristain, MD, Isa Bosse, MD, Hoai Bich Trinh, MD, Thomas B. Casale, MD, PhD, Pascal Demoly, MD, PhD, Moises A. Calderon, MD, PhD
Publicado no World Allergy Organization Journal (2023-06-01)

Allergic and hypersensitivity condition in the International Patients’ Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11

Por Luciana Kase Tanno, MD, PhD, Alain Perie, PhD, Jonathan A. Bernstein, MD, James L. Sublett, MD, Karapet Davtyan, MD, MPH, MBA, Frederic Berard, MD, PhD, Ruby Pawankar, MD, PhD, Marylin Valentin Rostan, MD, Herberto Chong, MD, PhD, Anahi Yañez, MD, Ignacio J. Ansontegui, MD, PhD, Motohiro Ebisawa, MD, PhD, Gary W.K. Wong, MD, PhD, Mario Morais-Almeida, MD, Bryan Martin, MD, Yann Briand, PhD, Pascal Demoly, MD, PhD
Publicado no World Allergy Organization Journal (2024-08-01)